Loblaw 3Q Profit, Revenue Beat as Food Inflation Continues to Rise
By Adriano Marchese
Loblaw on Wednesday said profit rose by nearly 12% in the third quarter thanks to stronger-than-expected revenue as more shoppers look for value amid rising costs of groceries in Canada.
The Canadian grocery retail giant posted higher net income of 624 million Canadian dollars ($455.7 million), or C$1.95 a share, up from C$559 million, or C$1.69 a share, in the comparable quarter a year ago.
Adjusted earnings were C$2.26 a share. According to FactSet, analysts were expecting C$2.24 a share.
Revenue rose to C$18.27 billion from C$17.39 billion. Analysts expected a rise to C$18.21 billion.
Behind the rise was a 4.5% increase in same-store food retail segment sales, and a 4.6% rise in same-store sales at its drug retail business.
Loblaw said its discount stores benefited from higher traffic in the period as customers look for value in their groceries, and that it continues to invest in opening new discount stores.
Meanwhile, retail gross margin declined in both its food and drug segments as a result of promotional investments and increased shrink. Higher sales and ongoing cost control initiatives drove adjusted net earnings growth in the quarter.
The high cost of living in Canada has been increasingly an issue, in large part due to the rising cost of food. According to the Canadian consumer price index, grocery inflation was rising at a rate of 5.8% year-over-year in September, a drop from 6.9% in August.
Loblaw said it has increased investments to lower food prices which were reflected in the company's internal food inflation, which was lower than Canada's food CPI.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
November 15, 2023 07:14 ET (12:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track